Efficacy and safety of catheter ablation versus antiarrhythmic drugs in patients with ischemic cardiomyopathy and ICD for secondary arrhythmia prevention: a systematic review and network meta-analysis

14 April 2026 (08:00 - 14:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Konstantinos Pamporis

National & Kapodistrian University of Athens Medical School, Athens (Greece)

188 More presentations in this session

Presentation thumbnail

Comparison of ECG findings between young patients with cryptogenic ischemic stroke and stroke-free control subjects

Doctor J. Uutela (Jyvaskyla, FI)

Presentation thumbnail

A wearable SCG-based approach for early, low-cost screening of valvular heart disease

Doctor V. Pergola (Naples, IT)

Presentation thumbnail

Intraoperative assessment of cardiac parasympathetic tone using short-term HRV metrics before and after atropine administration: a pilot study

Doctor B. Hrymniak (Wroclaw, PL)

Presentation thumbnail

Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance

Doctor Y. Shhab (Bucharest, RO)

Presentation thumbnail

Arrhythmias and device therapy in HFpEF: Insights from a real-world hospital cohort

Ms A. Bondoc (Timisoara, RO)

Abstract Slides Video

Access the full session

Session thumbnail

Poster session (3): mechanisms and management of arrhythmias

The Event

Event poster

EHRA 2026

14 April 2026 08:00 CET

You may be interested in

Congress Session

Risk reduction for ventricular arrhythmias: revisiting knowns and unknowns

Congress Presentation

Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?

Congress Presentation

Efficacy and safety of catheter ablation versus antiarrhythmic drug therapy in ventricular tachycardia management: a systematic review and meta-analysis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources